Sign in
You can sign in with one of these social accounts:
Search
Content
Industries
Ratings
Projects
Mind Brand
Mind on social media

Medicines

All storiesPublicationsNewsOpenmindVideo
Medicine
Cannabis in Ukraine: First reading of the bill – another step towards legalisation
Kristina Drogoziuk — 24 July 2023, 09:45
Medicine
What diseases threaten Ukrainians due to the explosion of the Kakhovka Hydroplant, and how to avoid them?
Kateryna Khutorna — 14 June 2023, 07:30
Company news
The Ukrainian manufacturers continue to supply more than 60% of the country's demand for medicinal products, according to the results of the first quarter analysis
Valerii Marchenko — 3 May 2023, 17:15
Finance
International organisations will no longer procure medicines for Ukraine – Ministry of Health
Ihor Yashkin — 25 January 2023, 17:50
Medicine
"Without you all": Could there be a shortage of imported medicines in Ukraine?
Vitaliі Kravchenko — 23 November 2022, 14:00
War

Pharma at war: Reorientation from anti-COVID drugs to hemostatics, destroyed warehouses and migration of pharmacists

How market players survive, interact with one another and overcome difficulties in the new situation
Kateryna Khutorna — 20 October 2022, 11:00
War

Fedorov: The occupiers have banned the importation of medicines and hygiene products into Melitopol

The mayor of the occupied city called this terror of civilians
Nadiya Palyvoda — 3 September 2022, 17:26
Medicine

Medicine at war: how the healthcare system has changed

How public and municipal hospitals work after 24 February and whether all services are available for patients
Kateryna Khutorna — 17 August 2022, 10:00
Special Project

Billions against epidemic: how pharmaceutical world is weathering the crisis

And why pharmacists spare no money on innovation
Sergiy Kucherenko — 15 October 2020, 11:00
Medicine

Healthy growth: why pharma’s future lies with generics

Ukrainian pharmaceutical market will grow and stay popular among the investors in the next years. The generic drugs producers will win the most
Sergiy Kucherenko — 15 November 2019, 07:30
Business

«Darnitsa» increases its net profit by 31%

No dividends will be paid. The net profit of UAH 449 134 thousands will be reinvested for the companys financial needs
Valerii Marchenko — 13 March 2019, 21:05
Society

Life Elixir: how a pharmaceutical company launched the production of infusions

And why is it unique for Ukraine.
Pavlo Harlamov, Viktor Gacenko — 10 May 2018, 12:30
Investments

Medical investment: where Ukrainian pharmacy needs support

What factors can attract foreign capital into the industry
Katerina Grebenik — 25 April 2018, 07:30
Investments

General director of pharmaceutical firm “Darnitsa”: “Import substitution is nothing more than another form of competition”

Svitlana Didenko speaks about market realities, public interests, patients’ preferences and the company’s readiness for the healthcare reform
5 April 2018, 09:45
© 2026 Mind, Future Media LLC